(Lipid Profiles and VCAM-1) in on Vascular Aterogenic Factors
11
Effect of Atorvastatin Treatment on Vascular Aterogenic Factors (Lipid Profiles and VCAM-1) in Patient Diabetes with Dyslipidemia by Budi Suprapti Submission date: 18-Mar-2020 11:54AM (UTC+0800) Submission ID: 1277385669 File name: id_Profiles_and_VCAM-1_in_Patient_Diabetes_with_Dyslipidemia.pdf (863.75K) Word count: 2325 Character count: 12615
Transcript of (Lipid Profiles and VCAM-1) in on Vascular Aterogenic Factors
Effect of Atorvastatin Treatmenton Vascular Aterogenic Factors(Lipid Profiles and VCAM-1) in
Patient Diabetes withDyslipidemia
by Budi Suprapti
Submission date: 18-Mar-2020 11:54AM (UTC+0800)Submission ID: 1277385669File name: id_Profiles_and_VCAM-1_in_Patient_Diabetes_with_Dyslipidemia.pdf (863.75K)Word count: 2325Character count: 12615
14%SIMILARITY INDEX
10%INTERNET SOURCES
11%PUBLICATIONS
0%STUDENT PAPERS
1 2%
2 2%
3 1%
4 1%
5 1%
6 1%
7
Effect of Atorvastatin Treatment on Vascular Aterogenic Factors(Lipid Profiles and VCAM-1) in Patient Diabetes with DyslipidemiaORIGINALITY REPORT
PRIMARY SOURCES
issuu.comInternet Source
Systems Biology of Free Radicals andAntioxidants, 2014.Publication
Fernando Fonseca, Marzia Macedo, Marisa daCunha Gonzaga, Carlos D'Aparecida Machado,Anna Batista. "Study of lipid profile in adultwomen with acne", Clinical, Cosmetic andInvestigational Dermatology, 2015Publication
www.acpm.orgInternet Source
run.unl.ptInternet Source
www.uspreventiveservicestaskforce.orgInternet Source
lllnutrition.comInternet Source
1%
8 1%
9 1%
10 1%
11 1%
12 1%
13 1%
14 1%
15 <1%
ijcep.comInternet Source
www.effcohealth.orgInternet Source
www.faqs.orgInternet Source
Márta Kasza, J. Meleg, J. Vardai, B. Nagy, E.Szalai, J. Damjanovich, A. Csutak, B. Ujhelyi, V.Nagy. "Plasma E-selectin levels can play a rolein the development of diabetic retinopathy",Graefe's Archive for Clinical and ExperimentalOphthalmology, 2016Publication
creativecommons.orgInternet Source
www.dovepress.comInternet Source
cdn.intechopen.comInternet Source
Mariusz Nowak. "Blood serum levels of vascularcell adhesion molecule (sVCAM-1), intercellularadhesion molecule (sICAM-1) and endothelialleucocyte adhesion molecule-1 (ELAM-1) in
16 <1%
17 <1%
18 <1%
19 <1%
20 <1%
diabetic retinopathy", Clinical and ExperimentalMedicine, 09/2008Publication
link.springer.comInternet Source
Gelaye, Bizu, Michelle A. Williams, SeblewengelLemma, Yemane Berhane, Jesse R. Fann, AnnVander Stoep, and Xiao-Hua Andrew Zhou."Major depressive disorder and cardiometabolicdisease risk among sub-Saharan Africanadults", Diabetes & Metabolic Syndrome ClinicalResearch & Reviews, 2015.Publication
Renier, G.. "Monocyte adhesion in diabeticangiopathy", Journal of Diabetes and ItsComplications, 200303/04Publication
P. K. Tingsgaard, T. Bock, P. L. La. "TopicalBudesonide Treatment Reduces EndothelialExpression of Intercellular Adhesion Molecules(Vascular Cell Adhesion Molecule-1 and P-selectin) and Eosinophil Infiltration in NasalPolyps", Acta Oto-Laryngologica, 2009Publication
"Systems Biology of Free Radicals andAntioxidants", Springer Science and BusinessMedia LLC, 2014
21 <1%
Exclude quotes Off
Exclude bibliography On
Exclude matches Off
Publication
Breuer, Hans-Willi M.. "Hypertriglyceridemia: AReview of Clinical Relevance and TreatmentOptions: Focus on Cerivastatin", CurrentMedical Research and Opinion, 2001.Publication
FINAL GRADE
/0
Effect of Atorvastatin Treatment on Vascular Aterogenic Factors(Lipid Profiles and VCAM-1) in Patient Diabetes with DyslipidemiaGRADEMARK REPORT
GENERAL COMMENTS
Instructor
PAGE 1
PAGE 2
PAGE 3
PAGE 4
PAGE 5
